CD86 and multiple sclerosis: As both our genotype data and data on existing treatments (Niino et al., 2009) indicate cell-subset-specific effects on CD86 expression in multiple sclerosis, in particular related to naïve B cells, such subset-specific effects may underlie this unexpected outcome.